Abide Therapeutics to Participate in February 2018 Investor Conferences

February 7, 2018

Responsive image

SAN DIEGO, Feb. 7, 2018 /PRNewswire/ — Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes, announced today that Alan Ezekowitz, CEO and President, will present an overview of the company…

Category: Precious Metals